Episode 822: Conexeu Sciences ($CNXU): The Future of Regenerative Aesthetics
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
Episode 822: Conexeu Sciences ($CNXU): The Future of Regenerative Aesthetics
-
Narrated by:
-
By:
This interview is disseminated on behalf of Conexeu Sciences Inc.
Conexeu Sciences (NASDAQ: CNXU) President and CEO Miles Harrison discusses how the company’s regenerative medicine platform could address the growing demand for tissue restoration driven by GLP-1 weight loss medications, extracellular matrix technology, multi-market strategy, and the future of bioregeneration.
Learn more: https://www.conexeu.com/
Watch the full YouTube interview here: https://youtu.be/FJUXvMrH5hU
And follow us to stay updated: https://www.youtube.com/GlobalOneMedia
adbl_web_anon_alc_button_suppression_t1
No reviews yet